Acadia Healthcare vs Concentra Group Holdings Parent
ACHC and CON side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ACHC and CON compare
Concentra Group Holdings Parent is the larger company, worth 1.8 times as much as Acadia Healthcare ($5.1B against $2.8B).
Concentra Group Holdings Parent grew revenue faster over the last twelve months (14.0% versus 4.3% for Acadia Healthcare).
Concentra Group Holdings Parent keeps more of each dollar of sales as profit, with a net margin of 8.7% compared with −33.4% at Acadia Healthcare.
Concentra Group Holdings Parent pays a dividend yielding 0.62%; Acadia Healthcare does not pay one.
Concentra Group Holdings Parent scores higher on the StockData Score (11 against 7 for Acadia Healthcare), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ACHC | CON |
|---|---|---|
| Size and price | ||
| Market cap | $2.8B | $5.1B |
| Share price | $29.96 | $40.38 |
| Change, 1 year | 30.2% | 101% |
| Change, 5 years | −53.3% | – |
| Beta (5Y) | 0.65 | 0.54 |
| Employees | 25K | 13K |
| StockData Score | ||
| Total score | 7 | 11 (better) |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 0 | 3 (better) |
| Health score | 2 | 2 |
| Dividend score | 0 | 3 (better) |
| Valuation | ||
| P/E | – | 26.2× |
| P/S | 0.8× (better) | 2.3× |
| P/B | 1.4× (better) | 10.8× |
| EV/EBITDA | – | 14.5× |
| P/FCF | – | 19.3× |
| FCF yield | −4.8% | 5.2% (better) |
| Fair value | $67.36 | $32.95 |
| Margin of safety | 55.5% (better) | −22.5% |
| Growth | ||
| Revenue growth (TTM) | 4.3% | 14.0% (better) |
| Revenue growth, 5Y average | 9.7% | – |
| Net income growth (TTM) | −909% | 33.1% (better) |
| EPS growth (TTM) | −938% | 29.4% (better) |
| Profitability | ||
| Gross margin | – | 29.3% |
| Operating margin | – | 16.4% |
| Net margin | −33.4% | 8.7% (better) |
| FCF margin | −4.0% | 11.7% (better) |
| Return on equity | −44.5% | 48.5% (better) |
| Return on invested capital | – | 15.1% |
| Financial health | ||
| Debt / equity | 1.22 (better) | 3.30 |
| Net debt / EBITDA | – | 3.11 |
| Current ratio | 1.57 (better) | 1.38 |
| Altman Z-score | 0.98 | 2.57 (better) |
| Piotroski F-score | 4 | 6 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.62% |
| Payout ratio | – | 16.1% |
| Years of dividend growth | – | 1 |
| Shareholder yield | 0.00% | 0.62% (better) |
| Ownership | ||
| Held by institutions | 145% | 88.2% |
| Held by insiders | 1.9% | 10.8% |
| Insider net buying, 12 months | – | −$14.6M |
| Short interest, % of float | 24.9% | 3.2% |
Go deeper
- ACHC stock overview
- ACHC income statement
- ACHC valuation and score
- CON stock overview
- CON income statement
- CON valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.